Joel R. Rosh

Children's Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

54h-index14.1kcitations395works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(254), Microscopic Colitis(143), Adolescent and Pediatric Healthcare(50), Immunodeficiency and Autoimmune Disorders(48), Eosinophilic Esophagitis(40)

Publications392 total

105 Ruxolitinib Therapy in Medically Refractory Pediatric IBD
The American Journal of Gastroenterology·2025
41: USTEKINUMAB OPEN-LABEL INDUCTION AND RANDOMIZED BLINDED MAINTENANCE THERAPY IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: THE PHASE 3 UNITI JR STUDY
Gastroenterology·2025
Children With Inflammatory Bowel Diseases are Disadvantaged by Current Drug Approval Policies: A Call for Urgent Change
Crohn s & Colitis 360·2025· 1 citedOpen Access
A158 APPLYING MACHINE LEARNING FOR PREDICTING TREATMENT RESPONSE TO VEDOLIZUMAB IN PEDIATRIC IBD BY SERUM METABOLOMICS
Journal of the Canadian Association of Gastroenterology·2025Open Access
DOP006 Long term maintenance treatment with vedolizumab in pediatric IBD: a three-year follow-up of the prospective multicenter VEDOKIDS study
Journal of Crohn s and Colitis·2025
Curbside Consultation in Pediatric GI
2024
Financial Disclosures
2024
Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long‐term extension results
Journal of Pediatric Gastroenterology and Nutrition·2024· 10 citedOpen Access
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease
Journal of Crohn s and Colitis·2024· 1 citedOpen Access
Understanding Predictors of Crohn’s Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn’s Disease
Journal of the Canadian Association of Gastroenterology·2024· 6 citedOpen Access
A prospective, controlled multisite trial of yoga in pediatric inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition·2023· 4 cited
Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization
Clinical Gastroenterology and Hepatology·2023· 21 citedOpen Access
The Future of Advanced Therapies for Pediatric Crohn’s Disease
Pediatric Drugs·2023· 4 cited
Exome Sequencing Implicates <i>DGKZ</i>, <i>ESRRA</i>, and <i>GXYLT1</i> for Modulating Granuloma Formation in Crohn Disease
Journal of Pediatric Gastroenterology and Nutrition·2023· 5 citedOpen Access
Safety Summary of Pediatric Inflammatory Bowel Disease Therapies
Gastroenterology Clinics of North America·2023· 3 cited
Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
2023
Tu1998 INITIAL THERAPY WITH CORTICOSTEROIDS RATHER THAN MESALAMINE AT DIAGNOSIS IMPROVES WEEK 4 BUT NOT WEEK 52 CLINICAL OUTCOMES IN CHILDREN PRESENTING WITH ULCERATIVE COLITIS AND MODERATELY HIGH PUCAI (50-60)
Gastroenterology·2023
Tu2009 USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE UNISTAR STUDY LONG-TERM EXTENSION
Gastroenterology·2023
Methotrexate
2023
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis
Journal of Crohn s and Colitis·2022· 6 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

Anne M. Griffiths(39), Jeffrey S. Hyams(37), James Markowitz(34), Subra Kugathasan(31), Anthony Otley(30), Maria Oliva‐Hemker(26), Neal S. LeLeiko(25), Jonathan Evans(24), David J. Keljo(23), Wallace Crandall(22), David Mack(21), David R. Mack(19), Marian Pfefferkorn(18), Robert N. Baldassano(17), Lee A. Denson(16), Athos Bousvaros(14), Trudy Lerer(13), Thomas D. Walters(12), Melvin B. Heyman(12), Susan S. Baker(11)